BIOENGINEER

Research report: Case Report: Twelve-year longitudinal CMR follow-up in Becker muscular dystrophy–associated cardiomyopathy

A 12-year CMR case report in a man with Becker muscular dystrophy found worsening ventricular remodelling, reduced ejection ...
Medscape

Tadalafil Relieves Ischemia in Becker Muscular Dystrophy

The drug tadalafil (Cialis, Lilly), already approved to treat erectile dysfunction and pulmonary hypertension, also corrects abnormal blood flow in exercised forearms of men with Becker muscular ...
University of Delaware

Groundbreaking muscular dystrophy research

When you think about children diagnosed with Duchenne and Becker muscular dystrophies, the first things that usually come to mind are difficulty walking and the progressive skeletal muscle wasting, ...
Yahoo Finance

Parent Project Muscular Dystrophy Expands Leadership Team to Accelerate Progress for Duchenne, Becker Community

WASHINGTON, Aug. 18, 2025 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), is pleased to announce the ...
Nasdaq

Capricor Therapeutics Receives Orphan Drug Designation for Deramiocel in Becker Muscular Dystrophy, Expanding Focus in Neuromuscular Diseases

Capricor Therapeutics announced that the U.S. FDA has granted Orphan Drug Designation to its lead cell therapy candidate, Deramiocel, for the treatment of Becker Muscular Dystrophy (BMD). This ...
markets.financialcontent

Muscular Dystrophy Association Announces Nearly $400K in Research Grants to Address Challenges in Duchenne Muscular Dystrophy Gene Therapy

"With these grants, we continue our longstanding collaboration with industry and academic partners to identify bottlenecks and ways to safely translate gene therapies for neuromuscular disorders.
Business Wire

Edgewise Receives European Medicines Agency (EMA) Orphan Drug Designations for Sevasemten (EDG-5506) for the Treatment of Becker and Duchenne Muscular Dystrophies

BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the European Medicines Agency (EMA) has granted ...
CBS 6

Father hosts cornhole tournament to fund muscular dystrophy research

SCHENECTADY, N.Y. — A father of two sons diagnosed with muscular dystrophy is organizing a cornhole tournament this weekend to raise money for research and awareness of the condition. Stephen Gilbert, ...

Sam's Night Celebrates 21 Years of Fighting to End Duchenne, Raises $1.7 Million for Parent Project Muscular Dystrophy

The Killian family of Rockwall, Texas, is celebrating another successful year of Sam's Night, their annual fundraiser benefiting Parent Project Muscular Dystrophy (PPMD), the leading U.S. nonprofit ...
WFMZ-TV

Parent Project Muscular Dystrophy, Foundation to Eradicate Duchenne Announce 2026 Advocacy Leadership Awards Recipients Honoring Bipartisan Champions in Congress

PR Newswire WASHINGTON, March 9, 2026 WASHINGTON, March 9, 2026 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), in partnership with the Foundation to Eradicate Duchenne (FED), today ...
WREG

Muscular Dystrophy Association Announces Nearly $400K in Research Grants to Address Challenges in Duchenne Muscular Dystrophy Gene Therapy

New York, NY, March 13, 2023 (GLOBE NEWSWIRE) -- Today, Muscular Dystrophy Association (MDA) announced two research grants designed to address potential transgene-triggered safety concerns in Duchenne ...